X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cytotoxicity (2) 2
index medicus (2) 2
oncology (2) 2
anticancer properties (1) 1
antitumor activity (1) 1
antitumor-activity (1) 1
article (1) 1
autoimmunity (1) 1
biocompatibility (1) 1
bystander activation (1) 1
cancer (1) 1
cancer-immunotherapy (1) 1
cell activation (1) 1
cs1 (1) 1
dexamethasone (1) 1
effector cells (1) 1
elotuzumab (1) 1
family receptors (1) 1
fc-gamma receptors (1) 1
fc-gamma-riiia (1) 1
fcγ receptor (1) 1
immune system (1) 1
immune tolerance (1) 1
immunobiology (1) 1
immunology (1) 1
in vivo methods and tests (1) 1
in-vivo (1) 1
increased expression (1) 1
lenalidomide (1) 1
lymphocytic choriomeningitis virus (1) 1
macrophages (1) 1
molecular mimicry (1) 1
monoclonal antibodies (1) 1
monoclonal-antibody (1) 1
mouse (1) 1
multiple myeloma (1) 1
multiple-myeloma (1) 1
natural killer cells (1) 1
natural-killer-cell (1) 1
phagocytosis (1) 1
phenotypes (1) 1
phospholipase c-gamma (1) 1
review (1) 1
t-cells (1) 1
therapy (1) 1
toxicity (1) 1
tumor-associated macrophages (1) 1
tumor-cells (1) 1
tumors (1) 1
viral infection (1) 1
xenografts (1) 1
xenotransplantation (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Viruses, ISSN 1999-4915, 09/2019, Volume 11, Issue 10, p. 885
Viral infections are a natural part of our existence. They can affect us in many ways that are the result of the interaction between the viral pathogen and our... 
lymphocytic choriomeningitis virus (LCMV) | bystander activation | molecular mimicry | immune tolerance | viral infection | autoimmunity
Journal Article
CANCER IMMUNOLOGY RESEARCH, ISSN 2326-6066, 10/2019, Volume 7, Issue 10, pp. 1633 - 1646
Elotuzumab (Elo) is an IgG(1) monoclonal antibody targeting SLAMF7 (CS1, CRACC, and CD319), which is highly expressed on multiple myeloma (MM) cells, natural... 
CS1 | DEXAMETHASONE | ONCOLOGY | FC-GAMMA-RIIIA | NATURAL-KILLER-CELL | FAMILY RECEPTORS | LENALIDOMIDE | MONOCLONAL-ANTIBODY | TUMOR-CELLS | IMMUNOLOGY | CYTOTOXICITY | PHOSPHOLIPASE C-GAMMA
Journal Article
Blood advances, ISSN 2473-9529, 05/2017, Volume 1, Issue 12, pp. 753 - 765
Elotuzumab, a humanized monoclonal antibody that binds human signaling lymphocytic activation molecule F7 (hSLAMF7) on myeloma cells, was developed to treat... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.